These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18514715)

  • 1. Progress or backsliding on HIV and illicit drugs in 2008?
    Csete J; Wolfe D
    Lancet; 2008 May; 371(9627):1820-1. PubMed ID: 18514715
    [No Abstract]   [Full Text] [Related]  

  • 2. UNGASS: time to put HIV at the forefront of drug policy.
    Lancet HIV; 2016 Apr; 3(4):e147. PubMed ID: 27036984
    [No Abstract]   [Full Text] [Related]  

  • 3. Time for legalized distribution of illegal drugs?
    Johnstone T
    CMAJ; 1997 Nov; 157(10):1345-6. PubMed ID: 9371058
    [No Abstract]   [Full Text] [Related]  

  • 4. The future of harm reduction programmes in Russia.
    Lancet; 2009 Oct; 374(9697):1213. PubMed ID: 19819371
    [No Abstract]   [Full Text] [Related]  

  • 5. Could a United Nations organisation lead to a worsening of drug-related harms?
    Wood E; Kerr T
    Drug Alcohol Rev; 2010 Jan; 29(1):99-100. PubMed ID: 20078689
    [No Abstract]   [Full Text] [Related]  

  • 6. State of the art science addressing injecting drug use, HIV and harm reduction.
    Beg M; Strathdee SA; Kazatchkine M
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S1-4. PubMed ID: 25727257
    [No Abstract]   [Full Text] [Related]  

  • 7. Discrimination, HIV among People Who Use Drugs, and the UNGASS 2016 on the World Drug Problem.
    Tinasti K; Ravishankar S; Zuniga JM
    J Int Assoc Provid AIDS Care; 2016 Jul; 15(4):273-5. PubMed ID: 27385648
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV treatment, injection drug use, and illicit drug policies.
    Wood E; Kerr T; Montaner JS
    Lancet; 2007 Jul; 370(9581):8-10. PubMed ID: 17617253
    [No Abstract]   [Full Text] [Related]  

  • 9. Deregulation of the sale and possession of syringes for HIV prevention among injection drug users.
    Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):71-2. PubMed ID: 7648287
    [No Abstract]   [Full Text] [Related]  

  • 10. The genesis of syringe prescription to prevent HIV in Rhode Island.
    Rich JD; McKenzie M; Macalino G; Runnarsdottir V; Gaydos M; Mehrotra M; Stein J; Whitlock T; Salas C; Burris S
    Health Matrix Clevel; 2001; 11(1):129-45. PubMed ID: 11345673
    [No Abstract]   [Full Text] [Related]  

  • 11. Harm reduction and control of HIV in IDUs in France.
    Carrieri MP; Spire B
    Lancet; 2008 Aug; 372(9637):448. PubMed ID: 18692713
    [No Abstract]   [Full Text] [Related]  

  • 12. Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy.
    Elliott R; Csete J; Wood E; Kerr T
    Health Hum Rights; 2005; 8(2):104-38. PubMed ID: 17136905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV/AIDS in India. The needle and the damage done.
    Cohen J
    Science; 2004 Apr; 304(5670):509-12. PubMed ID: 15105472
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescribing syringes to injection drug users: what the family physician should know.
    Rich JD; Taylor L; Mehrotra M; Mason R; Stozek M; Stancliff S
    Am Fam Physician; 2003 Jul; 68(1):45-7. PubMed ID: 12887113
    [No Abstract]   [Full Text] [Related]  

  • 15. National drug abuse situation in Vietnam--how accurate are the projections?
    Ray R
    Addiction; 2008 Apr; 103(4):544-5. PubMed ID: 18339099
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent trends in drug abuse in China.
    Fang YX; Wang YB; Shi J; Liu ZM; Lu L
    Acta Pharmacol Sin; 2006 Feb; 27(2):140-4. PubMed ID: 16412261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ethical aspects concerning the management of drug abuse in HIV].
    Santos y Vargas L
    P R Health Sci J; 1996 Sep; 15(3):237-41. PubMed ID: 9064699
    [No Abstract]   [Full Text] [Related]  

  • 18. People who use drugs, HIV, and human rights.
    Jürgens R; Csete J; Amon JJ; Baral S; Beyrer C
    Lancet; 2010 Aug; 376(9739):475-85. PubMed ID: 20650514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of ethical issues in prescribing and dispensing syringes to injection drug users.
    Lazzarini Z
    Health Matrix Clevel; 2001; 11(1):85-128. PubMed ID: 11345679
    [No Abstract]   [Full Text] [Related]  

  • 20. Harm reduction--a framework for incorporating science into drug policy.
    Des Jarlais DC
    Am J Public Health; 1995 Jan; 85(1):10-2. PubMed ID: 7832242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.